Commentary

Article

State of the Science Treatment Crossroads - Breast Cancer: Chaired by Shipra Gandhi, MD

State of the Science Treatment Crossroads - Breast Cancer: Chaired by Shipra Gandhi, MD

State of the Science Treatment Crossroads - Breast Cancer: Chaired by Shipra Gandhi, MD

Speakers

  • Shipra Gandhi, MD | Roswell Park Comprehensive Cancer Center
  • Maryam Lustberg, MD, MPH | Yale School of Medicine
  • Sheheryar Kabraji, MD, BMBCh | Roswell Park Comprehensive Cancer Center

Topics

  • How are you selecting CDK4/6 Inhibitors in Breast Cancer?
  • Sequencing after Frontline CDK4/6: Do you continue with a CDK4/6i or switch therapy?
  • New Kids on the Block: Antibody-Drug Conjugates (ADC) for Breast Cancer
  • Treatment Crossroads Workshop: Application of Data
Related Videos
Sara M. Tolaney, MD, MPH
Sara M. Tolaney, MD, MPH
Philip McCarthy, MD, director emeritus, Transplant & Cellular Therapy Program, member, Tumor Immunology and Immunotherapy Program, Roswell Park Comprehensive Cancer Center
Linda Vahdat, MD, MBA
Peter Forsyth, MD
Bruce G. Haffty, MD, MS, FACR, FASTRO